You are here: All Products  > Aslan Pharma Pays $129 Million for Global Rights to Lead Asset

Aslan Pharma Pays $129 Million for Global Rights to Lead Asset

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products